Company Profile

The Center for Anti-Infective Agents (CEFAIA) provides high-level support to pharmaceutical and biotech companies in their pursuit of anti-infective drug development and licensing programs.

Founded as a private independent consulting company in 1988 by Dr. Ursula Theuretzbacher, CEFAIA has deep experience assisting both start-up and established pharmaceutical and biotech companies worldwide to establish research portfolios, assess in-licensing opportunities, and streamline R&D strategy.

Dr. Theuretzbacher offers an integrated approach based on scientific expertise, knowledge of the anti-infective market, and international presence to help her clients put in place strategy and tactics to maximize returns on investment. As an invited speaker, reviewer, and professional organization board member, with multiple articles a year accepted by leading scientific publications, Dr. Theuretzbacher actively participates at the highest levels of the professional anti-infective communities.

Based in Vienna, Austria, CEFAIA has established an international reputation as the goto specialist for antibiotics and antifungals in science and business. Our clients include startup, as well as mid-stage and industry leading pharmaceutical companies in Europe, Canada, and the U.S with a focus on anti-infective agents.

Our programs in the anti-infective field include:

We collaborate with consultants and leading experts with recognized expertise in widely varying fields. Read more about our associates...